Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes - Steensma, D. P. (Blood, 2015)

Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions - Valent, P. (Oncotarget, 2017)

The World Health Organization (WHO) classification of the myeloid neoplasms - Vardiman, J. W.; Harris, N. L.; Brunning, R. D. (Blood, 2002)

Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers - Naqvi, K. (Blood, 2011)

Real-time deformability cytometry: on-the-fly cell mechanical phenotyping - Otto, O. (Nat. Methods, 2015)

Statistics for real-time deformability cytometry: Clustering, dimensionality reduction, and significance testing - Herbig, M.; Mietke, A.; Müller, P.; Otto, O. (Biomicrofluidics, 2018)

Viscoelastic properties of differentiating blood cells are fate- and function-dependent - Ekpenyong, A. E. (PLoS ONE, 2012)

Role of plasma gelsolin protein in the final stage of erythropoiesis and in correction of erythroid dysplasia in vitro - Han, S. Y.; Lee, E. M.; Kim, S.; Kwon, A. M.; Baek, E. J. (Int. J. Mol. Sci., 2020)

Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromes - Sundaravel, S. (Proc. Natl. Acad. Sci., 2015)

5q-myelodysplastic syndromes: Chromosome 5q genes direct a tumor-suppression network sensing actin dynamics - Eisenmann, K. M. (Oncogene, 2009)

Immunomodulatory drugs reorganize cytoskeleton by modulating Rho GTPases - Xu, Y. (Blood, 2009)

Reduced activation of protein kinase B, Rac, and F-actin polymerization contributes to an impairment of stromal cell-derived factor-1-induced migration of CD34+ cells from patients with myelodysplasia - Fuhler, G. M. (Blood, 2008)

IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells - Schinke, C. (Blood, 2015)

Breakdown of the endothelial barrier function in tumor cell transmigration - Mierke, C. T. (Biophys. J., 2008)

Ras-proximate-1 GTPase-activating protein and Rac2 may play pivotal roles in the initial development of myelodysplastic syndrome - Shao, X.; Miao, M.; Qi, X.; Chen, Z. (Oncol. Lett., 2012)

RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates fasudil as an antileukemic drug - Wermke, M. (Blood, 2015)

Bagging predictors - Breiman, L. (Mach. Learn., 1996)

Scikit-Learn: Machine Learning in Python - Pedregosa, F. (Springer, 2012)

Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: Problem areas - Goasguen, J. E. (Br. J. Haematol., 2018)

Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: Recommendations for a standardized approach - Bennett, J. M.; Orazi, A. (Haematologica, 2009)

Exploring dyserythropoiesis in patients with myelodysplastic syndrome by imaging flow cytometry and machine-learning assisted morphometrics - Rosenberg, C. A. (Cytom. B Clin. Cytom., 2020)

AIDeveloper: Deep learning image classification in life science and beyond - Kräter, M. (Adv. Sci., 2021)

Intelligent image-based deformation-assisted cell sorting with molecular specificity - Nawaz, A. A. (Nat. Methods, 2020)

Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: The role of B-cell precursors - Reis-Alves, S. C.; Traina, F.; Metze, K.; Lorand-Metze, I. (Diagn. Pathol., 2015)

Expression of CD34 on human B cell precursors - Schmitt, C.; Eaves, C. J.; Lansdorp, P. M. (Clin. Exp. Immunol., 2008)

Detection of human disease conditions by single-cell morpho-rheological phenotyping of blood - Toepfner, N. (Elife, 2018)

Sequencing technologies: The next generation - Metzker, M. L. (Nat. Rev. Genet., 2010)

Clinical and biological implications of driver mutations in myelodysplastic syndromes - Papaemmanuil, E. (Blood, 2013)

Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes - Nagata, Y. (Nat. Commun., 2019)

High-throughput cell mechanical phenotyping for label-free titration assays of cytoskeletal modifications - Golfier, S. (Cytoskeleton, 2017)

Real-time fluorescence and deformability cytometry - Rosendahl, P. (Nat. Methods, 2018)

Plasmodium falciparum erythrocyte-binding antigen 175 triggers a biophysical change in the red blood cell that facilitates invasion - Koch, M. (Proc. Natl. Acad. Sci., 2017)

Bone marrow histology and CD34 immunostaining in the prognostic evaluation of primary myelodysplastic syndromes - Oriani, A. (Br. J. Haematol., 1996)

CD34 immunohistochemistry of bone marrow biopsies: Prognostic significance in primary myelodysplastic syndromes - Soligo, D. A. (Am. J. Hematol., 1994)